Implantable cardioverter-defibrillator implantation for primary and secondary prevention: indications and outcomes

By  

Cardiology in the Young, Vol. 27, Iss. S1, 2017-01 ,pp. : S126-S131

Cambridge University Press

Access to resources Recommend Favorite

Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial – a prospective pilot study

By de Bie Mihaly K.   Lekkerkerker Jaco C.   van Dam Bastiaan   Gaasbeek Andre   van Buren Marjolijn   Putter Hein   van Erven Lieselot   Bax Jeroen J.   Schalij Martin J.   Rabelink Ton J.   Jukema J. Wouter  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2151-2157

Informa Healthcare

Access to resources Recommend Favorite

Cost‐Effectiveness of Implantable Cardioverter Defibrillator Therapy

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 13, Iss. S1, 2002-01 ,pp. : S114-S117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Shocks from Pacemaker Cardioverter Defibrillators Increase with Amiodarone in Patients at High Risk for Sudden Cardiac Death

By  

Cardiology, Vol. 100, Iss. 3, 2003-11 ,pp. : 143-148

Karger

Access to resources Recommend Favorite

Risk stratification for the primary prevention of arrhythmic sudden cardiac death in postinfarction patients

By  

Continuing Cardiology Education, Vol. 2, Iss. 3, 2016-09 ,pp. : 135-143

John Wiley & Sons Inc

Access to resources Recommend Favorite